NexImmune, Inc. has announced the adjournment of its Special Meeting of Stockholders, originally reconvened on July 19, 2024, to August 2, 2024. The meeting will be held virtually via live webcast. The record date for stockholders entitled to vote remains June 11, 2024. The agenda includes a critical proposal for stockholders to consider: the approval of the liquidation and dissolution of the Company and the Plan of Liquidation and Dissolution. Stockholders can view the Proxy Statement online and have several options to cast their vote: via the Internet, telephone, mail, or during the Special Meeting itself. Votes can be submitted until 11:59 p.m. Eastern Time on August 1, 2024. NexImmune has engaged Laurel Hill Advisory Group, LLC as its proxy solicitor to assist stockholders with the voting process and any related inquiries.

NexImmune, Inc. has announced the adjournment of its Special Meeting of Stockholders, originally reconvened on July 19, 2024, to August 2, 2024. The meeting will be held virtually via live webcast. The record date for stockholders entitled to vote remains June 11, 2024. The agenda includes a critical proposal for stockholders to consider: the approval of the liquidation and dissolution of the Company and the Plan of Liquidation and Dissolution. Stockholders can view the Proxy Statement online and have several options to cast their vote: via the Internet, telephone, mail, or during the Special Meeting itself. Votes can be submitted until 11:59 p.m. Eastern Time on August 1, 2024. NexImmune has engaged Laurel Hill Advisory Group, LLC as its proxy solicitor to assist stockholders with the voting process and any related inquiries.